SPANGARO, MARCO
 Distribuzione geografica
Continente #
EU - Europa 1.988
NA - Nord America 1.712
AS - Asia 1.146
SA - Sud America 169
Continente sconosciuto - Info sul continente non disponibili 92
AF - Africa 28
OC - Oceania 10
Totale 5.145
Nazione #
US - Stati Uniti d'America 1.616
RU - Federazione Russa 757
IT - Italia 502
SG - Singapore 399
CN - Cina 359
RO - Romania 265
BR - Brasile 133
HK - Hong Kong 118
VN - Vietnam 107
SE - Svezia 88
GB - Regno Unito 85
DE - Germania 75
CA - Canada 60
FR - Francia 59
IN - India 51
NL - Olanda 28
BD - Bangladesh 23
ES - Italia 22
FI - Finlandia 22
PL - Polonia 21
JP - Giappone 17
TR - Turchia 15
IE - Irlanda 13
AR - Argentina 12
AT - Austria 11
KR - Corea 10
MX - Messico 10
CR - Costa Rica 9
EC - Ecuador 9
LT - Lituania 9
CO - Colombia 8
CH - Svizzera 7
IL - Israele 7
ZA - Sudafrica 7
AU - Australia 6
MY - Malesia 6
ID - Indonesia 5
UZ - Uzbekistan 5
EG - Egitto 4
GH - Ghana 4
HN - Honduras 4
IQ - Iraq 4
NP - Nepal 4
NZ - Nuova Zelanda 4
BE - Belgio 3
JM - Giamaica 3
MA - Marocco 3
PH - Filippine 3
PK - Pakistan 3
PT - Portogallo 3
UA - Ucraina 3
BO - Bolivia 2
CL - Cile 2
CZ - Repubblica Ceca 2
GR - Grecia 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
KE - Kenya 2
KZ - Kazakistan 2
LY - Libia 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BG - Bulgaria 1
BM - Bermuda 1
BS - Bahamas 1
BY - Bielorussia 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GP - Guadalupe 1
GT - Guatemala 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
MR - Mauritania 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
VE - Venezuela 1
Totale 5.054
Città #
Singapore 227
Ashburn 222
San Jose 172
Moscow 155
Milan 137
Hong Kong 113
Dallas 103
Beijing 82
New York 65
Shanghai 62
Council Bluffs 60
Ho Chi Minh City 41
Los Angeles 40
Rome 37
Munich 36
Santa Clara 35
Hefei 34
Phoenix 32
Lauterbourg 30
Boardman 26
Montreal 23
São Paulo 22
Orem 21
Atlanta 20
Denver 20
Chennai 17
Hanoi 17
London 15
Seattle 15
Tokyo 15
Dublin 14
Helsinki 14
Poplar 14
Princeton 14
Brooklyn 13
Chicago 12
Genoa 12
Warsaw 12
Lawrence 11
Naples 11
Boston 10
Frankfurt am Main 10
Nuremberg 10
Pune 10
Toronto 10
Miano 8
San Francisco 8
Secaucus 8
Brescia 7
Guangzhou 7
Lentate sul Seveso 7
San José 7
Stockholm 7
The Dalles 7
Washington 7
Ankara 6
Bologna 6
City of London 6
Dalton 6
Houston 6
Philadelphia 6
Verona 6
Vienna 6
Amsterdam 5
Buffalo 5
Da Nang 5
Dhaka 5
Ferrara 5
Gwangjin-gu 5
Istanbul 5
Manchester 5
Miami 5
Padova 5
Tashkent 5
Turku 5
Auckland 4
Bari 4
Berlin 4
Brasília 4
Cairo 4
Chengdu 4
Columbus 4
Coventry 4
Florence 4
Fortaleza 4
Guwahati 4
Mexico City 4
Monza 4
Mumbai 4
Querétaro 4
Rho 4
Rio de Janeiro 4
Schenectady 4
Southwark 4
Avellino 3
Barbianello 3
Bengaluru 3
Bergamo 3
Bresso 3
Buena Park 3
Totale 2.346
Nome #
Clozapine to N-Desmethylclozapine ratio in treatment resistant schizophrenia: clinical implications from psychopathology to cognition 387
Microdosing Psychedelics to Restore Synaptic Density in Schizophrenia 368
COGNITIVE IMPAIRMENT IN SCHIZOPHRENIA: DISENTANGLING THE ROLE OF METABOLIC ALTERATIONS AND NEUROINFLAMMATION 307
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes 259
The cognitive architecture of verbal humor in schizophrenia 149
Cognitive Remediation for Inpatients With Schizophrenia: Effects of a Brief and Intensive Training 136
The kynurenine pathway in treatment-resistant schizophrenia at the crossroads between pathophysiology and pharmacotherapy 133
Clozapine tolerability in Treatment Resistant Schizophrenia: exploring the role of sex 127
Get up! Functional mobility and metabolic syndrome in chronic schizophrenia: Effects on cognition and quality of life 126
Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions 125
Improving outcome of treatment-resistant schizophrenia: effects of cognitive remediation therapy 125
Modeling the interplay of age at onset and sex on cognition in Schizophrenia 122
Psychotic Disorders 120
Deconstructing heterogeneity in schizophrenia through language: a semi-automated linguistic analysis and data-driven clustering approach 116
Communicative-pragmatic abilities mediate the relationship between cognition and daily functioning in schizophrenia 116
Combined effect of treatment-resistance and autistic traits on sociocognitive abilities in schizophrenia 115
Cognitive reserve profiles are associated with outcome in schizophrenia 113
Importance of the dysregulation of the kynurenine pathway on cognition in schizophrenia: a systematic review of clinical studies 105
Cognition in Schizophrenia: Modeling the Interplay between Interleukin-1β C-511T Polymorphism, Metabolic Syndrome, and Sex 105
Navigating the Complexity of Psychotic Disorders: A Systematic Review of EEG Microstates and Machine Learning 104
Neuroinflammation and kynurenines in schizophrenia: Impact on cognition depending on cognitive functioning and modulatory properties in relation to cognitive remediation and aerobic exercise 104
Disentangling Cognitive Heterogeneity in Psychotic Spectrum Disorders 104
Cognitive remediation in schizophrenia: What happens after 10 years? 103
Functional benefits of co-occurring autistic symptoms in schizophrenia is delimited by symptom severity 103
Targeting quality of life in schizophrenia: the fil rouge between metabolic syndrome and anxiety 102
Obsessive-compulsive symptoms moderates the effects of cognitive functioning on quality of life in clozapine-treated schizophrenia 101
Dysconnection in schizophrenia: Filling the dots from old to new evidence 101
Psychedelics and schizophrenia: a double-edged sword 99
Longitudinal course of cognition in schizophrenia: Does treatment resistance play a role? 97
Factors affecting cognitive remediation outcome in schizophrenia: The role of treatment resistance 89
Determinants of patient satisfaction in clozapine users: results from the Clozapine International Consortium (CLOZIN) 84
From semantic concreteness to concretism in schizophrenia: An automated linguistic analysis of speech produced in figurative language interpretation 84
Is longer treatment better? A comparison study of 3 versus 6 months cognitive remediation in schizophrenia 84
M202. SEX-RELATED DIFFERENCES IN CLOZAPINE SIDE EFFECTS IN PATIENTS WITH TREATMENT-RESISTANT SCHIZOPHRENIA 79
On the Implementation of Computerized Adaptive Observations for Psychological Assessment 74
Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation 69
Psychopharmacology 69
S67. TREATMENT-RESISTANCE AFFECTS LONG-TERM COGNITIVE TRAJECTORIES IN SCHIZOPHRENIA: A LONGITUDINAL STUDY 68
White matter integrity, clinical symptoms and quality of life in schizophrenia: a DTI study 67
Cerebral asymmetries in schizophrenia 67
Treatment-resistance as a predictor of cognitive remediation outcome in schizophrenia 61
Two is Better Than One: Potentiating Cognitive Remediation With Aerobic Exercise to Improve Cognition in Schizophrenia With a Randomized Controlled Trial 51
Profiling electrophysiological and linguistic markers: implications for clinical and functional outcome in schizophrenia 27
Totale 5.145
Categoria #
all - tutte 20.419
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.419


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 8 4 0 0 0 3 1 5 2
2022/2023201 28 21 8 3 26 28 16 24 7 9 17 14
2023/2024255 30 21 27 23 21 33 6 27 0 8 10 49
2024/20251.145 82 37 55 57 55 77 366 55 137 70 69 85
2025/20262.593 191 166 83 321 284 101 274 195 701 137 70 70
2026/2027919 196 279 167 277 0 0 0 0 0 0 0 0
Totale 5.145